• Akira, S., Uematsu, S.,Takeuchi, O., 2006. Pathogen recognition and innate immunity. Cell, 124, 783-801.

  • An, T., Li, S., Pan, W., Tien, P., Zhong, B., Shu, H.B.,Wu, S., 2015. DYRK2 Negatively Regulates Type I Interferon Induction by Promoting TBK1 Degradation via Ser527 Phosphorylation. PLoS Pathog, 11, e1005179.

  • Barber, G.N., 2011. Innate immune DNA sensing pathways:STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol, 23, 10-20.

  • Beyett, T.S., Gan, X., Reilly, S.M., Chang, L., Gomez, A.V., Saltiel, A.R., Showalter, H.D.,Tesmer, J.J.G., 2018. Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKKepsilon and Reveal Mechanisms for Selective Inhibition. Mol Pharmacol, 94, 1210-1219.

  • Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P.O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., Hopf, C., Huhse, B., Mangano, R., Michon, A.M., Schirle, M., Schlegl, J., Schwab, M., Stein, M.A., Bauer, A., Casari, G., Drewes, G., Gavin, A.C., Jackson, D.B., Joberty, G., Neubauer, G., Rick, J., Kuster, B.,Superti-Furga, G., 2004. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol, 6, 97-105.

  • Chen, T., Wang, D., Xie, T.,Xu, L.G., 2018. Sec13 is a positive regulator of VISA-mediated antiviral signaling. Virus Genes, 54, 514-526.

  • Cildir, G., Low, K.C.,Tergaonkar, V., 2016. Noncanonical NF-kappa B Signaling in Health and Disease. Trends in Molecular Medicine, 22, 414-429.

  • Cui, J., Li, Y., Zhu, L., Liu, D., Songyang, Z., Wang, H.Y.,Wang, R.F., 2012. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol, 13, 387-395.

  • Dogan, H., Blume, C., Patel, A., Jungwirth, G., Sogerer, L., Ratliff, M., Ketter, R., Herold-Mende, C., Jones, D.T.W., Wick, W., Vollmuth, P., Zweckberger, K., Reuss, D., Von Deimling, A.,Sahm, F., 2022. Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomas. Acta Neuropathol, 144, 799-802.

  • Fitzgerald, K.A., Mcwhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., Coyle, A.J., Liao, S.M.,Maniatis, T., 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol, 4, 491-496.

  • Gao, B., Yu, W., Lv, P., Liang, X., Sun, S.,Zhang, Y., 2021. Parkin overexpression alleviates cardiac aging through facilitating K63-polyubiquitination of TBK1 to facilitate mitophagy. Biochim Biophys Acta Mol Basis Dis, 1867, 165997.

  • He, H., Wu, Z., Li, S., Chen, K., Wang, D., Zou, H., Chen, H., Li, Y., Liu, Z.,Qu, C., 2020. TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression. Cancer Lett, 469, 380-389.

  • He, T.S., Chen, T., Wang, D.D.,Xu, L.G., 2018. HAUS8 regulates RLRVISA antiviral signaling positively by targeting VISA. Mol Med Rep, 18, 2458-2466.

  • He, T.S., Xie, T., Li, J., Yang, Y.X., Li, C.S., Wang, W.Y., Cao, L.Z., Rao, H., Ju, C.,Xu, L.G., 2019. THO Complex Subunit 7 Homolog Negatively Regulates Cellular Antiviral Response against RNA Viruses by Targeting TBK1. Viruses-Basel, 11.

  • Hou, F., Sun, L., Zheng, H., Skaug, B., Jiang, Q.-X.,Chen, Z.J., 2011. MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response. Cell, 146, 448-461.

  • Hu, M.M.,Shu, H.B., 2018. Cytoplasmic Mechanisms of Recognition and Defense of Microbial Nucleic Acids. Annu Rev Cell Dev Biol, 34, 357-379.

  • Huang, J.P., Li, J., Xiao, Y.P.,Xu, L.G., 2022. BAG6 negatively regulates the RLR signaling pathway by targeting VISA/MAVS. Front Immunol, 13, 972184.

  • Huang, L., Liu, H., Zhang, K., Meng, Q., Hu, L., Zhang, Y., Xiang, Z., Li, J., Yang, Y., Chen, Y., Cui, S., Tang, H., Pei, H., Bu, Z.,Weng, C., 2020. Ubiquitin-Conjugating Enzyme 2S Enhances Viral Replication by Inhibiting Type I IFN Production through Recruiting USP15 to Deubiquitinate TBK1. Cell Reports, 32.

  • Ivashkiv, L.B.,Donlin, L.T., 2014. Regulation of type I interferon responses. Nat Rev Immunol, 14, 36-49.

  • Kawai, T.,Akira, S., 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci, 1143, 1-20.

  • Kawai, T.,Akira, S., 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol, 21, 317-337.

  • Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J., Takeuchi, O.,Akira, S., 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology, 6, 981-988.

  • Lei, C.Q., Zhong, B., Zhang, Y., Zhang, J., Wang, S.,Shu, H.B., 2010. Glycogen synthase kinase 3beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity, 33, 878-889.

  • Li, X., Zhang, Q., Ding, Y.Y., Liu, Y.Q., Zhao, D.Z., Zhao, K., Shen, Q.C., Liu, X.G., Zhu, X.H., Li, N., Cheng, Z.Y., Fan, G.P., Wang, Q.Q.,Cao, X.T., 2016. Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity. Nature Immunology, 17, 806-+.

  • Ling, T., Li, S.N., Weng, G.X., Wang, W., Li, C., Cao, L., Rao, H., Shu, H.B.,Xu, L.G., 2018. TARBP2 negatively regulates IFN-beta production and innate antiviral response by targeting MAVS. Mol Immunol, 104, 1-10.

  • Ma, X.L., Helgason, E., Phung, Q.T., Quan, C.L., Iyer, R.S., Lee, M.W., Bowman, K.K., Starovasnik, M.A.,Dueber, E.C., 2012. Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proceedings of the National Academy of Sciences of the United States of America, 109, 9378-9383.

  • Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R.,Tschopp, R., 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature, 437, 1167-1172.

  • Morita, Y., Kanei-Ishii, C., Nomura, T.,Ishii, S., 2005. TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation. Mol Biol Cell, 16, 5433-5444.

  • Oral, E.A., Reilly, S.M., Gomez, A.V., Meral, R., Butz, L., Ajluni, N., Chenevert, T.L., Korytnaya, E., Neidert, A.H., Hench, R., Rus, D., Horowitz, J.F., Poirier, B., Zhao, P., Lehmann, K., Jain, M., Yu, R., Liddle, C., Ahmadian, M., Downes, M., Evans, R.M.,Saltiel, A.R., 2017. Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. Cell Metabolism, 26, 157-+.

  • Pillai, S., Nguyen, J., Johnson, J., Haura, E., Coppola, D.,Chellappan, S., 2015. Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis. Nat Commun, 6, 10072.

  • Pilli, M., Arko-Mensah, J., Ponpuak, M., Roberts, E., Master, S., Mandell, M.A., Dupont, N., Ornatowski, W., Jiang, S., Bradfute, S.B., Bruun, J.A., Hansen, T.E., Johansen, T.,Deretic, V., 2012. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity, 37, 223-234.

  • Richter, B., Sliter, D.A., Herhaus, L., Stolz, A., Wang, C., Beli, P., Zaffagnini, G., Wild, P., Martens, S., Wagner, S.A., Youle, R.J.,Dikic, I., 2016. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A, 113, 4039-4044.

  • Runde, A.P., Mack, R., S, J.P.,Zhang, J., 2022. The role of TBK1 in cancer pathogenesis and anticancer immunity. J Exp Clin Cancer Res, 41, 135.

  • Scudiero, I., Zotti, T., Ferravante, A., Vessichelli, M., Reale, C., Masone, M.C., Leonardi, A., Vito, P.,Stilo, R., 2012. Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFalpha-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein. J Biol Chem, 287, 6053-6061.

  • Seth, R.B., Sun, L.J., Ea, C.K.,Chen, Z.J.J., 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappa B and IRF3. Cell, 122, 669-682.

  • Song, G., Liu, B., Li, Z., Wu, H., Wang, P., Zhao, K., Jiang, G., Zhang, L.,Gao, C., 2016. E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1. Nat Immunol, 17, 1342-1351.

  • Takeuchi, O.,Akira, S., 2009. Innate immunity to virus infection. Immunol Rev, 227, 75-86.

  • Takeuchi, O.,Akira, S., 2010. Pattern recognition receptors and inflammation. Cell, 140, 805-820.

  • Tan, X., Sun, L., Chen, J.,Chen, Z.J., 2018. Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids. Annu Rev Microbiol, 72, 447-478.

  • Wang, L., Wang, L., Zhang, S., Qu, G., Zhang, D., Li, S.,Liu, S., 2013. Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer. Oncol Rep, 29, 283-287.

  • Wang, Y., Wang, F., Wu, Y., Zuo, L., Zhang, S., Zhou, Q., Wei, W., Wang, Y.,Zhu, H., 2015. MicroRNA-126 attenuates palmitate-induced apoptosis by targeting TRAF7 in HUVECs. Mol Cell Biochem, 399, 123-130.

  • Xiang, S., Song, S., Tang, H., Smaill, J.B., Wang, A., Xie, H.,Lu, X., 2021. TANK-binding kinase 1 (TBK1):An emerging therapeutic target for drug discovery. Drug Discov Today, 26, 2445-2455.

  • Xu, L.G., Li, L.Y.,Shu, H.B., 2004. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J Biol Chem, 279, 17278-17282.

  • Xu, L.G., Wang, Y.Y., Han, K.J., Li, L.Y., Zhai, Z.H.,Shu, H.B., 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Molecular Cell, 19, 727-740.

  • Yoshida, H., Jono, H., Kai, H.,Li, J.D., 2005. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J Biol Chem, 280, 41111-41121.

  • Zang, L., Gu, J., Yang, X., Yuan, Y., Guo, H., Zhou, W., Ma, J., Chen, Y., Wu, Y., Zheng, H.,Shi, W., 2023. Ubiquitin-specific protease 24 promotes EV71 infection by restricting K63-linked polyubiquitination of TBK1. Virol Sin, 38, 75-83.

  • Zhang, M., Wang, L., Zhao, X., Zhao, K., Meng, H., Zhao, W.,Gao, C., 2012. TRAF-interacting protein (TRIP) negatively regulates IFN-beta production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J Exp Med, 209, 1703-1711.

  • Zhang, Q., Zhang, X.,Dong, W., 2021. TRAF7 contributes to tumor progression by promoting ubiquitin-proteasome mediated degradation of P53 in hepatocellular carcinoma. Cell Death Discov, 7, 352.

  • Zhao, P., Wong, K.I., Sun, X.L., Reilly, S.M., Uhm, M., Liao, Z.J., Skorobogatko, Y.,Saltiel, A.R., 2018. TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue. Cell, 172, 731-+.

  • Zhu, Z., Aref, A.R., Cohoon, T.J., Barbie, T.U., Imamura, Y., Yang, S., Moody, S.E., Shen, R.R., Schinzel, A.C., Thai, T.C., Reibel, J.B., Tamayo, P., Godfrey, J.T., Qian, Z.R., Page, A.N., Maciag, K., Chan, E.M., Silkworth, W., Labowsky, M.T., Rozhansky, L., Mesirov, J.P., Gillanders, W.E., Ogino, S., Hacohen, N., Gaudet, S., Eck, M.J., Engelman, J.A., Corcoran, R.B., Wong, K.K., Hahn, W.C.,Barbie, D.A., 2014. Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. Cancer Discov, 4, 452-465.

  • Zotti, T., Scudiero, I., Vito, P.,Stilo, R., 2017. The Emerging Role of TRAF7 in Tumor Development. J Cell Physiol, 232, 1233-1238.

  • Zotti, T., Uva, A., Ferravante, A., Vessichelli, M., Scudiero, I., Ceccarelli, M., Vito, P.,Stilo, R., 2011. TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation. J Biol Chem, 286, 22924-22933.

  • Zotti, T., Vito, P.,Stilo, R., 2012. The seventh ring:exploring TRAF7 functions. J Cell Physiol, 227, 1280-1284.